Ballard C. G. et al. (2009). Management of agitation and aggression associated with Alzheimer disease. Nature Reviews Neurology, 5, 245–255.
Banerjee S. (2009). The Use of Antipsychotic Medication for People with Dementia: Time for Action. A Report for the Minister of State for Care Services. London: The Stationery Office.
Chen Y., Briesacher B. A., Field T. S., Tjia J., Lau D. T. and Gurwitz J. H. (2010). Unexplained variation across US nursing homes in antipsychotic prescribing rates. Archives of Internal Medicine, 170, 89–95.
Cummings J. L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D. A. and Gornbein J. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308–2314.
Everitt D. E., Fields D. R., Soumerai S. S. and Avorn J. (1991). Resident behavior and staff distress in the nursing home. Journal of the American Geriatrics Society, 39, 792–798.
Gauthier S. et al. (2010) Management of behavioral problems in Alzheimer's disease. International Psychogeriatrics, 22, 346–372.
Hughes C. M., Lapane K., Watson M. C. and Davies H. T. (2007). Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs and Aging, 24, 81–93.
Jeste D. V. et al. (2008). ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology, 33, 957–970.
Kamble P., Chen H., Sherer J. T. and Aparasu R. R. (2009). Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data. Drugs and Aging, 26, 483–492.
Kamble P., Sherer J., Chen H. and Aparasu R. (2010). Off-label use of second-generation antipsychotic agents among elderly nursing home residents. Psychiatric Services, 61, 130–136.
Kat M. G., de Jonghe J. F. M., Aalten P., Kalisvaart C. J., Dröes R. M. and Verhey F. R. J. (2002). Neuropsychiatric symptoms of dementia: psychometric aspects of the Dutch Neuropsychiatric Inventory (NPI). Tijdschrift voor Gerontologie en Geriatrie, 33, 150–155 (in Dutch).
Kim H. and Whall A. L. (2006). Factors associated with psychotropic drug usage among nursing home residents with dementia. Nursing Research, 55, 252–258.
Lange R. T., Hopp G. A. and Kang N. (2004). Psychometric properties and factor structure of the Neuropsychiatric Inventory Nursing Home version in an elderly neuropsychiatric population. International Journal of Geriatric Psychiatry, 19, 440–448.
Nijk R. M., Zuidema S. U. and Koopmans R. T. C. M. (2009). Prevalence and correlates of psychotropic drug use in Dutch nursing home patients with dementia. International Psychogeriatrics, 21, 485–493.
Nordic Council on Medicines (1990). Guidelines for ATC Classification. Oslo: WHO Collaborating Center for Drugs Statistics Methodology.
Rasbash J., Healy M., Browne W. and Cameron B. (1998). MLwiN. London: Multilevel Models Project Institute of Education, University of London.
Reisberg B., Ferris S., de Leon M. J. and Crook T. (1982). The Global Deterioration Scale (GDS) for assessment of primary degenerative dementia. American Journal of Psychiatry, 139, 1136–1139.
Schneider L. S. et al. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525–1538.
Selbaek G., Kirkevold O. and Engedal K. (2007). The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. International Journal of Geriatric Psychiatry, 22, 843–849.
Selbaek G., Kirkevold O. and Engedal K. (2008). Psychiatric and behavioural symptoms and the use of psychotropic medication in Special Care Units and Regular Units in Norwegian nursing homes. Scandinavian Journal of Caring Sciences, 22, 568–573.
Shah S. M., Carey I. M., Harris T., Dewilde S. and Cook D. G. (2011). Antipsychotic prescribing to older people living in care homes and the community in England and Wales. International Journal of Geriatric Psychiatry. 26, 423–434.
Snijders T. A. B. and Bosker R. J. (1999). Multilevel Analysis. An Introduction to Basic and Advanced Multilevel Modelling. London: SAGE Publications.
Stafford A. C., Alswayan M. S. and Tenni P. C. (2011). Inappropriate prescribing in older residents of Australian care homes. Journal of Clinical Pharmacy and Therapeutics, 36, 33–44.
Testad I. et al. (2010). Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England. International Journal of Geriatric Psychiatry, 25, 725–731.
Wetzels R. B., Zuidema S. U., de Jonghe J. F., Verhey F. R. and Koopmans R. T. (2010). Course of neuropsychiatric symptoms in residents with dementia in nursing homes over a 2-year period. American Journal of Geriatric Psychiatry, 18, 1054–1065.
Wood S. et al. (2000). The use of the Neuropsychiatric Inventory in nursing home residents: characterization and measurement. American Journal of Geriatric Psychiatry, 8, 75–83.
Wood-Mitchell A., James I. A., Waterworth A., Swann A. and Ballard C. (2008). Factors influencing the prescribing of medications by old age psychiatrists for behavioral and psychological symptoms of dementia: a qualitative study. Age and Ageing, 37, 547–552.
Zuidema S. U., de Jonghe J. F. M., Verhey F. R. J. and Koopmans R. T. C. M. (2007a). Neuropsychiatric symptoms in nursing home patients: factor structure invariance of the Dutch nursing home version of the Neuropsychiatric Inventory in different stages of dementia. Dementia and Geriatric Cognitive Disorders, 24, 169–176.
Zuidema S. U., Verhey F. R. J., Derksen E. and Koopmans R. T. C. M. (2007b). Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. International Journal of Geriatric Psychiatry, 22, 632–638.
Zuidema S. U., de Jonghe J. F. M., Verhey F. R. J. and Koopmans R. T. C. M. (2010). Environmental correlates of neuropsychiatric symptoms in Dutch nursing home patients with dementia. International Journal of Geriatric Psychiatry, 25, 14–22.